U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 99

Tests names and labsConditionsGenes, analytes, and microbesMethods

Glioma susceptibility 2, 613028; GLM2 (Glial tumor) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Glioma susceptibility 2, 613028; GLM2 (Glial tumor) (PTEN gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

ALG8

Institute for Human Genetics University Medical Center Freiburg
Germany
21
  • C Sequence analysis of the entire coding region

CNS tumour panel (20 genes)

Molecular Genetics Laboratory North York General Hospital
Canada
1920
  • C Sequence analysis of the entire coding region

Invitae eMERGE Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
5916
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoBreast

Centogene AG - the Rare Disease Company
Germany
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11368
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
155107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

PTEN - MLPA

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis

PTEN - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer + RNA Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
14263
  • D Deletion/duplication analysis

Invitae Common Hereditary Cancers + RNA Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
11447
  • D Deletion/duplication analysis

Invitae eMERGE Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
5916
  • D Deletion/duplication analysis

Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
971680
  • D Deletion/duplication analysis

Invitae Inborn Errors of Immunity and Cytopenias Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
754562
  • D Deletion/duplication analysis

Invitae Neurodevelopmental Disorders Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
404241
  • D Deletion/duplication analysis

CancerNext® 37

Ambry Genetics
United States
7937
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CancerNext® 37 (+RNAinsight®)

Ambry Genetics
United States
7918
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 99

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.